MariMed Inc (MRMD)
OTHER OTC:MRMD
Want to see MRMD full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.01Last Year’s EPS
0Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a cautiously optimistic tone: the company delivered year-over-year revenue growth, positive adjusted EBITDA, stable gross margins above 40%, strong wholesale momentum in Delaware and Illinois, and robust loyalty/digital adoption—offset by expected seasonal retail softness, sequential declines in revenue and EBITDA, ongoing price compression in several markets, a continued GAAP net loss and a modest decline in cash. Management emphasized brand strength, operational discipline, and opportunities from medical rescheduling and state-level expansion (Massachusetts cap increase, Ohio store opening, licensing activity in NY/PA/Maine) while acknowledging near-term headwinds.Company Guidance
Quarterly Revenue and YoY Growth
Q1 2026 revenue of $39.5 million, up $1.6 million or 4.2% year-over-year, demonstrating continued top-line growth despite seasonal softness.
Positive Adjusted EBITDA and Margin Expansion
Adjusted EBITDA of $3.6 million representing a 9% EBITDA margin; EBITDA increased ~$1.1 million year-over-year and margin expanded from 7% to 9% YoY, showing improved operating leverage.
Positive Operating Cash Flow
Company generated positive cash flow from operations in the quarter while investing approximately $800,000 in targeted capex and license renewals.
Strong Gross Profit and Stable Margins
Gross profit of $15.8 million with a gross margin of 40.1%; gross margin was relatively stable sequentially (up ~20 basis points) and remains at/above 40% supported by operational discipline.
Wholesale Momentum in Key Markets
Wholesale revenue grew 4% year-over-year. Standouts: Delaware wholesale increased 373% YoY (pro forma) and 13% sequentially; Illinois wholesale increased 22% YoY and 25% sequentially, broadening distribution and market penetration.
Brand and Category Leadership
Betty's Eddies was the #1 selling edible across IL/MA/MD/DE combined; Vibations beverage remained top 5 across those states; multiple category #1 rankings (e.g., Nature's Heritage/First State flower in DE).
Retail Loyalty and Digital Adoption
Retail revenue grew 5% YoY (despite seasonal decline sequentially); loyalty program accounted for ~80% of retail revenue, membership grew 10% in Q1, and active loyalty members totaled ~398,000. Over 50% of orders placed prior to store pickup (online/app).
Improved GAAP Net Loss Trend and Operating Expense Control
GAAP net loss narrowed to $3.8 million from $4.6 million last quarter and $5.4 million YoY; operating expenses declined ~$500,000 YoY driven by lower bad debt expense and reduced marketing spend.
MRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2026 | $0.08 | $0.08 | -3.57% |
Mar 11, 2026 | $0.08 | $0.08 | -2.53% |
Nov 05, 2025 | $0.11 | $0.10 | -9.09% |
Aug 06, 2025 | $0.11 | $0.10 | -9.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does MariMed Inc (MRMD) report earnings?
MariMed Inc (MRMD) is schdueled to report earning on Aug 12, 2026, TBA (Confirmed).
What is MariMed Inc (MRMD) earnings time?
MariMed Inc (MRMD) earnings time is at Aug 12, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MRMD EPS forecast?
MRMD EPS forecast for the fiscal quarter 2026 (Q2) is -0.01.